$BANT
Bantec, Inc. Stock $bant

$bant Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023002427 Filed on January 12, 2023

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$606.2K	$943.4K	$2.466M
YoY Change	50.74%	142.73%	1.78%
Cost Of Revenue	$511.2K	$789.8K	$2.048M
YoY Change	66.36%	143.64%	31.84%
Gross Profit	$94.95K	$153.6K	$418.0K
YoY Change	0.14%	138.17%	-51.92%
Gross Profit Margin	15.66%	16.28%	16.95%
Selling, General & Admin	$514.3K	$507.9K	$2.180M
YoY Change	-21.4%	-8.9%	-23.09%
% of Gross Profit	541.64%	330.59%	521.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$8.930K	$8.931K
YoY Change			21.18%
% of Gross Profit		5.81%	2.14%
Operating Expenses	$514.3K	$516.8K	$2.225M
YoY Change	-21.4%	-7.29%	-21.72%
Operating Profit	-$419.3K	-$363.2K	-$1.807M
YoY Change	-25.05%	-26.33%	-8.41%
Interest Expense	-$362.3K	-$376.3K	-$1.229M
YoY Change	23.46%	-7.51%	-14.98%
% of Operating Profit
Other Income/Expense, Net	-$362.3K	-$370.00	$866.4K
YoY Change	23.46%		-1055.49%
Pretax Income	-$781.7K	-$640.4K	-$2.673M
YoY Change	-8.36%	-12.15%	42.04%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$781.7K	-$1.224M	-$2.673M
YoY Change	-8.36%	67.98%	42.04%
Net Earnings / Revenue	-128.95%	-129.79%	-108.4%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	5.864B shares	4.317B shares	3.425B shares
Diluted Shares Outstanding	5.327B shares		3.425B shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$94.94K	$186.4K	$186.4K
YoY Change	-87.86%	-81.1%	-81.1%
Cash & Equivalents	$94.94K	$186.4K
Short-Term Investments
Other Short-Term Assets	$4.660K	$4.660K	$4.660K
YoY Change	-34.55%	-83.86%	-83.86%
Inventory	$92.37K	$92.92K	$92.92K
Prepaid Expenses
Receivables	$116.5K	$420.0K	$420.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$308.5K	$703.9K	$703.9K
YoY Change	-68.43%	-41.59%	-41.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.461K	$1.461K	$35.03K
YoY Change	-98.03%	0.0%	-59.83%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change		-100.0%
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$22.01K	$35.03K	$35.03K
YoY Change	-90.77%	-86.07%	-86.07%
TOTAL ASSETS
Total Short-Term Assets	$308.5K	$703.9K	$703.9K
Total Long-Term Assets	$22.01K	$35.03K	$35.03K
Total Assets	$330.5K	$738.9K	$739.0K
YoY Change	-72.82%	-49.27%	-49.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.611M	$2.730M	$2.730M
YoY Change	-3.54%	2.37%	2.37%
Accrued Expenses	$5.355M	$5.094M	$5.129M
YoY Change	15.94%	18.03%	17.41%
Deferred Revenue
YoY Change
Short-Term Debt	$834.0K	$837.0K	$837.0K
YoY Change	-3.47%	-4.66%	-4.66%
Long-Term Debt Due	$7.715M	$7.654M	$7.654M
YoY Change	0.04%	-2.28%	-2.28%
Total Short-Term Liabilities	$16.68M	$16.50M	$16.50M
YoY Change	3.78%	3.71%	3.71%
LONG-TERM LIABILITIES
Long-Term Debt	$126.7K	$127.5K	$127.5K
YoY Change	-58.1%	-57.94%	-57.94%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$126.7K	$127.5K	$127.5K
YoY Change	-60.92%	-62.27%	-62.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.68M	$16.50M	$16.50M
Total Long-Term Liabilities	$126.7K	$127.5K	$127.5K
Total Liabilities	$16.80M	$16.63M	$16.63M
YoY Change	2.5%	2.33%	2.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.41M	-$35.63M
YoY Change		8.11%
Common Stock	$586.4K	$440.7K
YoY Change		78.4%
Preferred Stock		$13.44K
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$17.20M	-$16.58M	-$15.89M
YoY Change
Total Liabilities & Shareholders Equity	$330.5K	$738.9K	$739.0K
YoY Change	-72.82%	-49.27%	-49.27%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	-$781.7K	-$1.224M	-$2.673M
YoY Change	-8.36%	67.98%	42.04%
Depreciation, Depletion And Amortization		$8.930K	$8.931K
YoY Change			21.18%
Cash From Operating Activities	-$133.5K	-$403.6K	-$1.644M
YoY Change	-61.81%	-39.36%	4.28%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$42.06K	346.9K	$844.6K
YoY Change	-71.07%	-77.92%	-65.43%
NET CHANGE
Cash From Operating Activities	-$133.5K	-403.6K	-$1.644M
Cash From Investing Activities		0.000
Cash From Financing Activities	$42.06K	346.9K	$844.6K
Net Change In Cash	-$91.45K	-56.73K	-$799.6K
YoY Change	-55.22%	-106.59%	-197.28%
FREE CASH FLOW
Cash From Operating Activities	-$133.5K	-$403.6K	-$1.644M
Capital Expenditures		$0.00	$0.00
Free Cash Flow	-$133.5K	-$403.6K	-$1.644M
YoY Change		-35.0%	7.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Aggregate Intrinsic Value Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueForfeited		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55789
CY2022	dei	Entity Registrant Name EntityRegistrantName	BANTEC, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0967943
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 Paterson Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Falls
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07424
CY2022	dei	City Area Code CityAreaCode	(203)
CY2022	dei	Local Phone Number LocalPhoneNumber	220-2296
CY2022	dei	Security12g Title Security12gTitle	COMMON STOCK, $0.0001 PAR VALUE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	2171943	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5864107732	shares
CY2022	dei	Auditor Firm AuditorFirmId	106
CY2022	dei	Auditor Name AuditorName	SALBERG & COMPANY, P.A.
CY2022	dei	Auditor Location AuditorLocation	Boca Raton, Florida
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	186386	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	985953	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	419951	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128386	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	92917	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	61837	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4663	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28882	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	703917	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	1205058	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1461	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1461	usd
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44650	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33568	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85747	usd
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	119670	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	35029	usd
CY2021Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	251528	usd
CY2022Q3	us-gaap	Assets Assets	738946	usd
CY2021Q3	us-gaap	Assets Assets	1456586	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2730309	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2667110	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5094394	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4316258	usd
CY2022Q3	bant	Convertible Notes Payable Net Of Discounts And Premiums ConvertibleNotesPayableNetOfDiscountsAndPremiums	7422326	usd
CY2021Q3	bant	Convertible Notes Payable Net Of Discounts And Premiums ConvertibleNotesPayableNetOfDiscountsAndPremiums	7662640	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	837000	usd
CY2021Q3	us-gaap	Notes Payable NotesPayable	873000	usd
CY2021Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4885	usd
CY2022Q3	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	217897	usd
CY2021Q3	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	170036	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	13537	usd
CY2022Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	154562	usd
CY2021Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	42850	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34475	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	52178	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	125693	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16504500	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15914650	usd
CY2022Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	127539	usd
CY2021Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	303202	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34812	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	127539	usd
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	338014	usd
CY2022Q3	us-gaap	Liabilities Liabilities	16632039	usd
CY2021Q3	us-gaap	Liabilities Liabilities	16252664	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	685440	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4407320832	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4407320832	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2470510585	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2470510585	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	440733	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	247052	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18610920	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17913710	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35630186	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32956840	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-16578533	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-14796078	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	738946	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1456586	usd
CY2022	us-gaap	Revenues Revenues	2466198	usd
CY2021	us-gaap	Revenues Revenues	2422996	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2048173	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1553516	usd
CY2022	us-gaap	Gross Profit GrossProfit	418025	usd
CY2021	us-gaap	Gross Profit GrossProfit	869480	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2180288	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2834856	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	35719	usd
CY2022	us-gaap	Depreciation Depreciation	8931	usd
CY2021	us-gaap	Depreciation Depreciation	7374	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2224938	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2842430	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1806913	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1972750	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7068	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1220730	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1440220	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-370075	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-1536815	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8710	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5916	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	866433	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-90679	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2673346	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1882071	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2673346	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1882071	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	584072	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3257418	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1882071	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3424570305	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1425249598	shares
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17944973	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	82308	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	77400	usd
CY2021	bant	Stock Issued During Period Value Shares Issued To Non Employees For Services StockIssuedDuringPeriodValueSharesIssuedToNonEmployeesForServices	148000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	119670	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3083930	usd
CY2021	bant	Stock Issued During Period Value Conversion Of Notes Including Premiums StockIssuedDuringPeriodValueConversionOfNotesIncludingPremiums	1519658	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1882071	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14796078	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	69108	usd
CY2022	bant	Stock Issued During Period Value Cancellationof Shares Issued StockIssuedDuringPeriodValueCancellationofSharesIssued	-119670	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	699589	usd
CY2022	bant	Stock Issued During Period Value Conversion Of Notes Including Premiums StockIssuedDuringPeriodValueConversionOfNotesIncludingPremiums	625549	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	200387	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	-570632	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13440	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2673346	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16578533	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2673346	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1882071	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	69108	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	250709	usd
CY2022	bant	Stock Based Fee Conversion Of Loans StockBasedFeeConversionOfLoans	9884	usd
CY2021	bant	Stock Based Fee Conversion Of Loans StockBasedFeeConversionOfLoans	6830	usd
CY2022	us-gaap	Depreciation Depreciation	8931	usd
CY2021	us-gaap	Depreciation Depreciation	7374	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35719	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	157446	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	183992	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	258557	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	407186	usd
CY2021	bant	Net Gain On Settlement Of Accounts Payable And Accrued Expenses NetGainOnSettlementOfAccountsPayableAndAccruedExpenses	31479	usd
CY2022	bant	Net Debt Extinguishment Loss From Note Amendment NetDebtExtinguishmentLossFromNoteAmendment	-370075	usd
CY2021	bant	Net Debt Extinguishment Loss From Note Amendment NetDebtExtinguishmentLossFromNoteAmendment	-1505336	usd
CY2022	bant	Noncash Rent Expense NoncashRentExpense	-336	usd
CY2021	bant	Noncash Rent Expense NoncashRentExpense	848	usd
CY2022	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	196000	usd
CY2021	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	62500	usd
CY2022	bant	Gain Loss On Change In Fmv Of Derivative GainLossOnChangeInFMVOfDerivative	8710	usd
CY2021	bant	Gain Loss On Change In Fmv Of Derivative GainLossOnChangeInFMVOfDerivative	5916	usd
CY2021	us-gaap	Loan Processing Fee LoanProcessingFee	2670	usd
CY2022	bant	Accounts Receivable AccountsReceivable	-291565	usd
CY2021	bant	Accounts Receivable AccountsReceivable	221003	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31080	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	17238	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-24219	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6521	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	961654	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	703927	usd
CY2022	bant	Increase Decrease In Settlement Payable IncreaseDecreaseInSettlementPayable	7958	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1644132	usd
CY2022	bant	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueExercisableNumber		usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1576648	usd
CY2021	bant	Purchase Of Patent Intangible PurchaseOfPatentIntangible	44650	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44650	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	699589	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3083930	usd
CY2022	bant	Proceeds From Note Payable Related Party Net ProceedsFromNotePayableRelatedPartyNet	101250	usd
CY2021	bant	Proceeds From Note Payable Related Party Net ProceedsFromNotePayableRelatedPartyNet	487500	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	122766	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18000	usd
CY2022	bant	Net Proceeds From Ppp Loan Payable NetProceedsFromPPPLoanPayable	390000	usd
CY2021	bant	Net Proceeds From Ppp Loan Payable NetProceedsFromPPPLoanPayable	752382	usd
CY2022	bant	Repayment Of Factoring Notes RepaymentOfFactoringNotes	232763	usd
CY2021	bant	Repayment Of Factoring Notes RepaymentOfFactoringNotes	880624	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4885	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	36724	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	125000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	190000	usd
CY2022	bant	Repayment Note Payable Related Party RepaymentNotePayableRelatedParty	-110860	usd
CY2021	bant	Repayment Note Payable Related Party RepaymentNotePayableRelatedParty	-190000	usd
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	60400	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-60400	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	945227	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	844565	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2443237	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-799567	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	821939	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	985953	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	164014	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	186386	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	985953	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	37551	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	501690	usd
CY2022	bant	Original Issue Discounts Notes OriginalIssueDiscountsNotes	65500	usd
CY2021	bant	Original Issue Discounts Notes OriginalIssueDiscountsNotes	180533	usd
CY2022	bant	Issuance Of Common Stock For Note Conversions IssuanceOfCommonStockForNoteConversions	374501	usd
CY2021	bant	Issuance Of Common Stock For Note Conversions IssuanceOfCommonStockForNoteConversions	822545	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	18744	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	60298	usd
CY2022	bant	Reclassification Of Debt Premium Upon Conversion ReclassificationOfDebtPremiumUponConversion	222420	usd
CY2021	bant	Reclassification Of Debt Premium Upon Conversion ReclassificationOfDebtPremiumUponConversion	629984	usd
CY2021	bant	Issuance Of Common Stock For Accrued Salary IssuanceOfCommonStockForAccruedSalary	57000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	570632	usd
CY2022	bant	Issuance Of Convertible Preferred Stock Charged To Debt Discounts IssuanceOfConvertiblePreferredStockChargedToDebtDiscounts	101368	usd
CY2022	bant	Dividend On Convertible Preferred Stock DividendOnConvertiblePreferredStock	13440	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	200387	usd
CY2022	bant	Proceeds From Stock Option Exercised ProceedsFromStockOptionExercised	-119670	usd
CY2021	bant	Proceeds From Stock Option Exercised ProceedsFromStockOptionExercised	119670	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	4000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="font-variant: small-caps"><span style="text-decoration:underline">NATURE OF OPERATIONS</span></span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bantec, Inc. is a product and service company targeting the U.S. Government, state governments, municipalities, hospitals, universities, manufacturers and other building owners. Bantec also provides product procurement, distribution, and logistics services through its wholly-owned subsidiary, Howco Distributing Co., (“Howco”) (collectively, the “Company”) to the United States Department of Defense and Defense Logistics Agency. The Company established Bantec Sanitizing in fiscal 2021, which offers sanitizing products and equipment through its new store bantec.store. Bantec Sanitizing is currently offering Bantec Sanitizing franchises for sale. The Company has operations based in Little Falls, New Jersey and Vancouver, Washington. The Company continues to seek strategic acquisitions and partnerships that offer us an opportunity to grow sales and profit.</p>
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2673346	usd
CY2022Q3	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	1644132	usd
CY2022	bant	Working Capital Deficit WorkingCapitalDeficit	15800583	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	16578533	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35630186	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of intangible assets for impairment analysis, valuation of the lease liability and related right-of-use asset, valuation of stock-based compensation, the valuation of derivative liabilities, valuation of redeemable preferred stock and the valuation allowance on deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2020Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	128628	usd
CY2021	bant	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Losses Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossesIncludedInOtherComprehensiveIncome	-8851	usd
CY2021	bant	Derivative Losses On Derivative DerivativeLossesOnDerivative	5916	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	125693	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8710	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	134403	usd
CY2022	us-gaap	Recapitalization Costs RecapitalizationCosts	2000	usd
CY2022	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	0	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	7374	usd
CY2022	bant	Salvageable Value SalvageableValue	1461	usd
CY2022	us-gaap	Legal Fees LegalFees	44650	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2022	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	61032	usd
CY2021	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	47716	usd
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	42777527	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	4480000000	shares
CY2022	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	31756035787	shares
CY2021	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	2549848072	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	38476052210	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2592642822	shares
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	156554	usd
CY2022Q3	bant	Options Outstanding And Exercisable OptionsOutstandingAndExercisable	16423	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2240000000	shares
CY2022	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	8405055	usd
CY2022	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	31756035787	shares
CY2022	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	38,476,052,210
CY2022	bant	Shares Converted Percentage SharesConvertedPercentage	0.0499	pure
CY2022	bant	Outstanding Shares Percentage OutstandingSharesPercentage	0.0999	pure
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16423	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	17223	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2240000000	shares
CY2022	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company filed Form PRE 14C to effect a reverse split of between 1:500 and 1:1,000 shares of common stock. The Company expects approval in January 2023. The table below shows the Losses Per Share prior to the reverse split and following the reverse split. A key assumption to the earnings per share calculation is that post-reverse split price is equal to the pre-reverse split times the number of shares from the ratio. For example: pre-reverse split price of $0.003 times the reverse split of 1,000 is equal to $0.30.
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	3257418	usd
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	1882071	usd
CY2022	bant	Current Weighted Average Shares Outstanding CurrentWeightedAverageSharesOutstanding	3424570305	shares
CY2021	bant	Current Weighted Average Shares Outstanding CurrentWeightedAverageSharesOutstanding	1425249598	shares
CY2022	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0.0009
CY2021	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0.001
CY2022Q3	us-gaap	Shares Outstanding SharesOutstanding	3424570	shares
CY2021Q3	us-gaap	Shares Outstanding SharesOutstanding	1425250	shares
CY2022	bant	Loss Per Share LossPerShare	0.958
CY2021	bant	Loss Per Share LossPerShare	1.32
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	61837	usd
CY2020Q2	bant	Accrued Interests AccruedInterests	17000	usd
CY2020Q2	bant	Accrued Interests AccruedInterests	17000	usd
CY2020Q2	bant	Accrued Interests AccruedInterests	17000	usd
CY2022	us-gaap	Segment Reporting Description Of All Other Segments SegmentReportingDescriptionOfAllOtherSegments	Howco generates 94% of the consolidated sales which are primarily from department of defense. Drone LLC generated 6% of sales primarily to state and municipal government purchases of drones and accessories. Bantec Sanitizing Inc. had less than 1% of consolidated sales of its sanitizing products. Howco has 68% of the consolidated tangible assets, Drone has no allocated assets and Bantec Sanitizing Inc. has 4% of consolidated asset. The parent company has 29% of the consolidated tangible assets. and Additionally, there are no formal cost allocations to Howco or the other subsidiaries.
CY2021Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4885	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	419951	usd
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	128386	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	419951	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128386	usd
CY2022	bant	Bad Debt Expense BadDebtExpense	0	usd
CY2021	bant	Bad Debt Expense BadDebtExpense	0	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	92917	usd
CY2022	us-gaap	Legal Fees LegalFees	44650	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8931	usd
CY2022	bant	Net Carrying Value NetCarryingValue	35719	usd
CY2022Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	50000	usd
CY2021	bant	Extinguieshment Of Debt Amount ExtinguieshmentOfDebtAmount	377194	usd
CY2020Q2	bant	Principal And Interest Balance PrincipalAndInterestBalance	the Company amended the note with a principal and interest balance of $195,000, and $17,947
CY2018Q3	bant	Settlement Agreement Relating To Past Due Charges Amount SettlementAgreementRelatingToPastDueChargesAmount	127056	usd
CY2020Q1	bant	Initial Payment Amount InitialPaymentAmount	12706	usd
CY2020Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	6500	usd
CY2020Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3850	usd
CY2022Q2	us-gaap	Payments For Fees PaymentsForFees	7042	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	5000	usd
CY2022Q3	us-gaap	Settlement Assets Current SettlementAssetsCurrent	119670	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	36821330	shares
CY2022	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	154562	usd
CY2021	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	42850	usd
CY2022	bant	Debt Instrument Interest Rates During Period DebtInstrumentInterestRatesDuringPeriod	0.055	pure
CY2022	bant	Debt Instrument Default Interest Rate DebtInstrumentDefaultInterestRate	0.08	pure
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	17000	usd
CY2020Q1	bant	Nonconvertible Note NonconvertibleNote	17000	usd
CY2020Q1	bant	Accrued Interests AccruedInterests	17000	usd
CY2020Q1	bant	Accrued Interests AccruedInterests	17000	usd
CY2022	bant	Interest Annual Rate InterestAnnualRate	0.07	pure
CY2020Q2	us-gaap	Convertible Debt ConvertibleDebt	840000	usd
CY2020Q2	bant	Debt Instrument Increase Accrued Interests DebtInstrumentIncreaseAccruedInterests	688444	usd
CY2020Q2	bant	Debt Instrument Increases Accrued Interest DebtInstrumentIncreasesAccruedInterest	210409	usd
CY2020Q2	bant	Common Stock Percentage CommonStockPercentage	0.50	pure
CY2020Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2020Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	688444	usd
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	377194	usd
CY2020	bant	Debt Instrument Increases Accrued Interest DebtInstrumentIncreasesAccruedInterest	221323	usd
CY2021	bant	Converted Or Paid In Cash Long With Accrued Interest ConvertedOrPaidInCashLongWithAccruedInterest	224370	usd
CY2021	bant	Debt Instrument Increase Accrued Interests DebtInstrumentIncreaseAccruedInterests	0	usd
CY2020Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	180750	usd
CY2021Q3	bant	Shortterm Advances Total ShorttermAdvancesTotal	60400	usd
CY2022	us-gaap	Capitalized Exploratory Well Cost Charged To Expense1 CapitalizedExploratoryWellCostChargedToExpense1	18945	usd
CY2022	bant	Amortization Of Debt Discounts Premium AmortizationOfDebtDiscountsPremium	21940	usd
CY2021	bant	Amortization Of Debt Discounts Premium AmortizationOfDebtDiscountsPremium	30533	usd
CY2016Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7000	shares
CY2017Q2	bant	Debt Instrument Embedded Conversion Amount DebtInstrumentEmbeddedConversionAmount	617647	usd
CY2017Q2	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.25	pure
CY2019Q3	bant	Securities Shares Issued SecuritiesSharesIssued	1273261	shares
CY2018Q3	bant	Securities Shares Issued SecuritiesSharesIssued	101624	shares
CY2019Q4	bant	Shares Cancelled SharesCancelled	194520	shares
CY2018	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	308100	usd
CY2019	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	270320	usd
CY2021Q3	bant	Convertible Debt Balance Amount ConvertibleDebtBalanceAmount	421587	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Premium Current DebtInstrumentUnamortizedPremiumCurrent	281054	usd
CY2020Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2020Q1	us-gaap	Receivable With Imputed Interest Premium ReceivableWithImputedInterestPremium	93850	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2200	usd
CY2020	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	5277	usd
CY2021Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	0	usd
CY2020Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	91300	usd
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	usd
CY2021Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	91300	usd
CY2019Q3	bant	Receivable Amount ReceivableAmount	20000	usd
CY2020Q3	bant	Accrued Interests AccruedInterests	17000	usd
CY2020Q3	bant	Accrued Interests AccruedInterests	17000	usd
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	15000	usd
CY2020Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2021	bant	Principal Balance Amounted PrincipalBalanceAmounted	45000	usd
CY2022	bant	Principal Balance Amounted PrincipalBalanceAmounted	752	usd
CY2021Q3	bant	Convertible Promissory Notes ConvertiblePromissoryNotes	15000	usd
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2021Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022	bant	Debt Premium DebtPremium	15000	usd
CY2021	bant	Deposit Liabilities Accrued Interest1 DepositLiabilitiesAccruedInterest1	378	usd
CY2021Q3	bant	Convertible Notes Payables ConvertibleNotesPayables	15000	usd
CY2022	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2021Q3	bant	Debt Premium DebtPremium	15000	usd
CY2021Q3	bant	Convertible Notes Payables ConvertibleNotesPayables	15000	usd
CY2021Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2021Q3	bant	Debt Premium DebtPremium	15000	usd
CY2021Q4	bant	Convertible Notes Payables ConvertibleNotesPayables	15000	usd
CY2021Q4	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2021Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2021Q4	bant	Debt Premium DebtPremium	15000	usd
CY2022	bant	Deposit Liabilities Accrued Interest1 DepositLiabilitiesAccruedInterest1	0	usd
CY2021Q4	bant	Convertible Notes Payables ConvertibleNotesPayables	15000	usd
CY2021Q4	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2021Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2021Q4	bant	Debt Premium DebtPremium	15000	usd
CY2022Q1	us-gaap	Cash Cash	85000	usd
CY2021Q4	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2021Q4	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2021Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022	us-gaap-sup	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	105000	usd
CY2022Q1	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q1	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2022Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q1	bant	Debt Premium DebtPremium	15000	usd
CY2022	bant	Principal And Accrued Interest PrincipalAndAccruedInterest	744	usd
CY2022Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	15000	usd
CY2022Q1	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q1	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2022Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q1	bant	Debt Premium DebtPremium	15000	usd
CY2022Q1	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q2	bant	Debt Premium DebtPremium	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q2	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2022Q2	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q2	bant	Debt Premium DebtPremium	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q3	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q3	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q3	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q3	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q3	bant	Debt Premium DebtPremium	15000	usd
CY2022	bant	Frondeur Notes FrondeurNotes	105000	usd
CY2021	bant	Livingston Notes LivingstonNotes	45000	usd
CY2022	bant	Deposit Liabilitie Accrued Interes DepositLiabilitieAccruedInteres	3631	usd
CY2021	bant	Deposit Liabilitie Accrued Interes DepositLiabilitieAccruedInteres	752	usd
CY2018Q3	bant	Debt Issuance DebtIssuance	6000	usd
CY2018Q3	bant	Debt Instrument Debt Default Percentage DebtInstrumentDebtDefaultPercentage	0.12	pure
CY2018Q3	bant	Debt Instrument Convertible Conversion Rate Description DebtInstrumentConvertibleConversionRateDescription	The conversion feature allows for conversion into common shares at the lesser of: a) 70% of the share price on the date of the note; or b) 50% of the lowest bid price during the 30 trading days preceding the date of the notice of conversion. In connection with the issuance of this Note, the Company determined that the terms of the Note contain a conversion formula that caused variations in the conversion price resulting in the treatment of the conversion option as a bifurcated derivative to be accounted for at fair value.
CY2018Q3	bant	Derivative Liability DerivativeLiability	6000	usd
CY2018Q3	bant	Derivative Expense DerivativeExpense	4035	usd
CY2018Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6000	usd
CY2019Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	8881	usd
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5000	usd
CY2019	bant	Interest Expense And Debt Discount Balances InterestExpenseAndDebtDiscountBalances	0	usd
CY2022	bant	Extinguishment Of Debt Description ExtinguishmentOfDebtDescription	During the year ended September 30, 2021 the note principal was fully repaid in cash and the derivative liability was recognized as gain on extinguishment of debt. The following notes have been issued to the law firm, each having six-month term to maturity and 12% annual interest but a change in the conversion terms such that a fixed discount of 50% of the lowest bid price in the 30 trading days immediately preceding the notice of conversion. The notes have cross default provisions. The Company has accounted for the convertible promissory notes as stock settled debt under ASC 480 and recorded debt premiums equal to the face value of the notes with a charge to interest expense. The note principal amount was charged to professional fees during the month the note was issued.
CY2019Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2022Q2	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q2	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q3	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q3	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q3	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022	bant	Agreement Owned Amount AgreementOwnedAmount	20000	usd
CY2021	bant	Agreement Owned Amount AgreementOwnedAmount	0	usd
CY2018Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	90000	usd
CY2018Q4	bant	Vendor Settlement VendorSettlement	161700	usd
CY2018Q4	us-gaap	Debt Conversion Description DebtConversionDescription	The note bears interest at 5%, matures on June 30, 2019 and is convertible into the Company’s common stock at 50% of the lowest closing bid price during the 20 trading days immediately preceding the notice of conversion.
CY2018Q4	bant	Debt Premium Charge To Interest Expense DebtPremiumChargeToInterestExpense	90000	usd
CY2022Q3	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	53750	usd
CY2022Q3	bant	Accrued Interested AccruedInterested	2688	usd
CY2022Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	28942	usd
CY2022Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	615500	usd
CY2021Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	519054	usd
CY2022Q3	bant	Debt Instrument Discount Amount DebtInstrumentDiscountAmount	270064	usd
CY2021Q3	bant	Debt Instrument Discount Amount DebtInstrumentDiscountAmount	45816	usd
CY2022Q3	bant	Debt Instrument Total DebtInstrumentTotal	345436	usd
CY2021Q3	bant	Debt Instrument Total DebtInstrumentTotal	473238	usd
CY2022Q3	bant	Less Current Portions LessCurrentPortions	-217897	usd
CY2021Q3	bant	Less Current Portions LessCurrentPortions	-170036	usd
CY2022Q3	bant	Noncurrent Noncurrent	127539	usd
CY2021Q3	bant	Noncurrent Noncurrent	303202	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	135506	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	149614	usd
CY2019Q4	bant	Note Principal And Accrued Interest Related Description NotePrincipalAndAccruedInterestRelatedDescription	Conversion terms were reinstated and the note and accrued interest of $1,770 were fully converted into common stock during the year ended September 30, 2021. $17,000 was charged to loss on debt extinguishment due to reinstatement of conversion feature treated as stock settled debt in accordance with ASC 480.
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22461	usd
CY2021	bant	Accrued Interest AccruedInterest	30000	usd
CY2021	bant	Note Principal And Accrued Interest Related Description NotePrincipalAndAccruedInterestRelatedDescription	$2,260
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9674	usd
CY2022	bant	Issuance Of Discount Amortization Amount IssuanceOfDiscountAmortizationAmount	0	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.98	pure
CY2021	bant	Number Of Notes Payable NumberOfNotesPayable	seven
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	17500	usd
CY2021	bant	Service Vendor Fee ServiceVendorFee	-2500	usd
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2022	bant	Service Arrangement ServiceArrangement	17500	usd
CY2021	bant	Service Arrangement ServiceArrangement	17500	usd
CY2022	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	0.0002
CY2022	bant	Debt Instrument Convertible Conversion Price DebtInstrumentConvertibleConversionPrice	0.50	pure
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.50	pure
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	101368	usd
CY2022Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	461440	usd
CY2022Q3	bant	Additional Paid In Capital Including Dividends AdditionalPaidInCapitalIncludingDividends	360072	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	13440	usd
CY2022Q3	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.5
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0002
CY2022	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.50	pure
CY2022Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	224000	usd
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.22	pure
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Capital Shares Reserved For Future Issuance PreferredStockCapitalSharesReservedForFutureIssuance	3999750	shares
CY2022Q3	bant	Preferred Stock Shares Designated PreferredStockSharesDesignated	250	shares
CY2022	bant	Common Stock Dividend CommonStockDividend	0.99
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4407320832	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2470510585	shares
CY2020Q3	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provided for the issuance of up to 1,500,000,000 shares of common stock at a price of $.00175, under subscriptions.
CY2021Q1	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provides for the issuance of up to 1,250,000,000 shares of common stock at a price of $.0175, under subscriptions.
CY2021Q2	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provides for the issuance of up to 1,500,000,000 shares of common stock at a price of $.0025, under subscriptions.
CY2022Q1	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provides for the issuance of up to 1,800,000,000 shares of common stock at a price of $.0006, under subscriptions.
CY2022Q3	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provides for the issuance of up to 5,000,000,000 shares of common stock at a price of $.0002, under subscriptions.
CY2021Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1928898	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	120000000	shares
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	300000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	50000000	shares
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	125000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000000	shares
CY2021Q3	bant	Offering And Recieved OfferingAndRecieved	250000	usd
CY2020Q4	bant	Agreement Description AgreementDescription	On October 22, 2020, the Company issued 10,000,000 shares of common stock to a consultant for services rendered, which were valued at $0.0034, based on the stock price on the date of the grant. The cost of $34,000 was charged to consulting expense.
CY2021Q2	bant	Agreement Description AgreementDescription	On April 13, 2021, the Company issued 10,000,000 shares of common stock to a consultant for services, which were valued at $0.0114, based on the stock price on the date of the grant. The cost of $114,000 was charged to consulting expense.
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	36821330	shares
CY2022	bant	Weighted Average Exercise Price Anti Dilution Adjustment WeightedAverageExercisePriceAntiDilutionAdjustment
CY2021	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	119670	usd
CY2021	bant	Accrued Interest Paid AccruedInterestPaid	92723	usd
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	26947	usd
CY2021Q3	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	119670	usd
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	518649906	shares
CY2021	bant	Debt Premium DebtPremium	630000	usd
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1124318577	shares
CY2022Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	55000	usd
CY2022Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	55000	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2750	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2750	usd
CY2022Q2	bant	Shares Of Common Stock SharesOfCommonStock	197639860	shares
CY2022Q2	bant	Shares Of Common Stock SharesOfCommonStock	197639860	shares
CY2022Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	15000	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	747	usd
CY2022Q2	bant	Shares Of Common Stock SharesOfCommonStock	95214750	shares
CY2022Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	15000	usd
CY2022Q3	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	744	usd
CY2022Q3	bant	Shares Of Common Stock SharesOfCommonStock	126925600	shares
CY2022Q3	us-gaap	Convertible Debt ConvertibleDebt	222000	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17755	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220
CY2021	bant	Weighted Average Remaining Contractual Term Years Outstanding Beginning WeightedAverageRemainingContractualTermYearsOutstandingBeginning	P5Y3M14D
CY2021Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsForfeited	-532	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17223	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	230
CY2021	bant	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y8M15D
CY2022Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsForfeited	-800	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16423	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	220
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y11M19D
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0002
CY2022Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	78612	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	638984	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	749200	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	955971	usd
CY2022Q3	bant	Reduction Of Lease Liabilities ReductionOfLeaseLiabilities	122079	usd
CY2021Q3	bant	Reduction Of Lease Liabilities ReductionOfLeaseLiabilities	69564	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	25484484	shares
CY2020Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	0.0019
CY2021	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Beginning WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableBeginning	P2Y1M9D
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	71866	usd
CY2021	bant	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award Anti Dilution Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAwardAntiDilutionAdjustment	17293043	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	42777527	shares
CY2021Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	0.00112
CY2021	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Ending WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableEnding	P1Y1M9D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	93255	usd
CY2022	bant	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award Anti Dilution Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAwardAntiDilutionAdjustment	356479390	shares
CY2022	bant	Surrender Of Warrantsin Dollars SurrenderOfWarrantsinDollars	-399256917	usd
CY2022	bant	Number Of Warrants Issuance Of Warrants NumberOfWarrantsIssuanceOfWarrants	2240000000	usd
CY2022	bant	Weighted Average Exercise Price Issuance Of Warrant WeightedAverageExercisePriceIssuanceOfWarrant	0.0002	shares
CY2022	bant	Weighted Average Remaining Contractual Term Years Issuance Of Warrants WeightedAverageRemainingContractualTermYearsIssuanceOfWarrants	P6Y9M
CY2022	bant	Weighted Average Grant Date Fair Value Issuance Of Warrants WeightedAverageGrantDateFairValueIssuanceOfWarrants	0.0002
CY2022	bant	Aggregate Intrinsic Value Issuance Of Warrants AggregateIntrinsicValueIssuanceOfWarrants	448000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2240000000	shares
CY2022Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	0.0002
CY2022	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Ending WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableEnding	P6Y6M
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0002
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	224000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2016Q3	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.90	pure
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	5541	usd
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	9704	usd
CY2022Q3	bant	Operating Lease Liabilities At Inception OperatingLeaseLiabilitiesAtInception	156554	usd
CY2021Q3	bant	Operating Lease Liabilities At Inception OperatingLeaseLiabilitiesAtInception	156554	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	370000	usd
CY2022	us-gaap	Loss On Contract Termination LossOnContractTermination	2500000	usd
CY2019Q3	bant	Annual Salary AnnualSalary	624000	usd
CY2017Q1	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.10	pure
CY2017Q1	us-gaap	Shares Issued SharesIssued	250	shares
CY2017Q1	bant	Employment Agreement Vesting Period EmploymentAgreementVestingPeriod	P5Y
CY2019Q3	bant	Modified Salary ModifiedSalary	275000	usd
CY2019Q3	bant	Annual Bonus AnnualBonus	0.02	pure
CY2021	us-gaap	Other Expenses OtherExpenses	90866	usd
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000000	shares
CY2021Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.0114
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	57000	usd
CY2022	bant	Net Operating Loss Carryforwards Description NetOperatingLossCarryforwardsDescription	As of September 30, 2022, the Company has net operating loss carryforwards of approximately $17,382,000 to reduce future taxable income. Of the $17,382,000, approximately $14,604,000 can be used through 2039, and $2,778,000 may be carried forward indefinitely.
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	bant	Net Gain On Settlement Of Accounts Payable And Accrued Expenses NetGainOnSettlementOfAccountsPayableAndAccruedExpenses		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-561403	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-395235	usd
CY2022	bant	Current State And Local Tax Expenses Benefit CurrentStateAndLocalTaxExpensesBenefit	-225898	usd
CY2021	bant	Current State And Local Tax Expenses Benefit CurrentStateAndLocalTaxExpensesBenefit	-159035	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-40511	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1040685	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	873096	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	872055	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	827377	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	826390	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5147202	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4400030	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6847675	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6098475	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6847675	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6098475	usd
CY2022	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	$3,000
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	36821330	shares
CY2022	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	119670	shares
CY2019Q2	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisions	218637	usd
CY2019Q3	bant	Past Due Amounts PastDueAmounts	59000	usd
CY2020Q4	bant	Lawsuit Seeking Payment lawsuitSeekingPayment	276430	usd
CY2020Q4	bant	Finance Charge FinanceCharge	40212	usd
CY2022	us-gaap	Other Commitments Description OtherCommitmentsDescription	The agreement has an initial term of three years with one year renewals.
CY2017Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	360000	usd
CY2020Q2	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	On April 16, 2020 the Company’s subsidiary Howco renewed its office and warehouse lease in Vancouver, WA for a term commencing on June 1, 2020 extending through June 1, 2023 at an initial monthly rent of approximately $5,154.
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	156554	usd
CY2022Q3	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.10	pure
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee		usd
CY2022Q3	bant	Operating Lease At Inception OperatingLeaseAtInception	156554	usd
CY2021Q3	bant	Operating Lease At Inception OperatingLeaseAtInception	156554	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122986	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70807	usd
CY2022Q3	bant	Right Of Use Asset RightOfUseAsset	33568	usd
CY2021Q3	bant	Right Of Use Asset RightOfUseAsset	85747	usd
CY2022Q3	bant	Total Lease Liabilities Related To Rou TotalLeaseLiabilitiesRelatedToRou	34475	usd
CY2021Q3	bant	Total Lease Liabilities Related To Rou TotalLeaseLiabilitiesRelatedToRou	86990	usd
CY2021Q3	bant	Less Current Portion LessCurrentPortion	52178	usd
CY2021Q3	bant	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	34812	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	42929	usd
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	106298	usd
CY2022Q3	bant	Discount To Fair Value DiscountToFairValue	8454	usd
CY2021Q3	bant	Discount To Fair Value DiscountToFairValue	19308	usd
CY2022Q3	bant	Total Lease Liability Rou TotalLeaseLiabilityROU	34475	usd
CY2021Q3	bant	Total Lease Liability Rou TotalLeaseLiabilityROU	86990	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	42929	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42929	usd
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	73346	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	68246	usd
CY2019Q4	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	In December 2019, the Company relocated its primary office to 195 Paterson Avenue, Little Falls, New Jersey, under a one-year lease with a renewal option having monthly payments of $500.
CY2022	bant	Employees Earned Salary EmployeesEarnedSalary	0	usd
CY2021	bant	Employees Earned Salary EmployeesEarnedSalary	0	usd
CY2021	bant	Increase Decrease In Settlement Payable IncreaseDecreaseInSettlementPayable		usd
CY2022	bant	Purchase Of Patent Intangible PurchaseOfPatentIntangible		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	bant	Federally Insured Limit Amount FederallyInsuredLimitAmount	250000	usd
CY2022	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	0	usd
CY2021	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2022Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceForfeited
CY2022	bant	Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Remaining Contractual Term Years Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingContractualTermYearsForfeited
CY2022Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueForfeited		usd
CY2022	bant	Issued Shares Of Common Stock IssuedSharesOfCommonStock	496667000	shares
CY2022	bant	Offering And Received OfferingAndReceived	99333	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2021Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000000	shares
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1425249598	shares
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	bant	Issuance Of Common Stock For Accrued Salary IssuanceOfCommonStockForAccruedSalary		usd
CY2021	bant	Issuance Of Convertible Preferred Stock Charged To Debt Discounts IssuanceOfConvertiblePreferredStockChargedToDebtDiscounts		usd
CY2021	bant	Dividend On Convertible Preferred Stock DividendOnConvertiblePreferredStock		usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022	bant	Weighted Average Remaining Contractual Term Years Anti Dilution Adjustment WeightedAverageRemainingContractualTermYearsAntiDilutionAdjustment
CY2022	bant	Weighted Average Grant Date Fair Value Anti Dilution Adjustment WeightedAverageGrantDateFairValueAntiDilutionAdjustment
CY2022	bant	Aggregate Intrinsic Value Anti Dilution Adjustment AggregateIntrinsicValueAntiDilutionAdjustment		usd
CY2022	bant	Weighted Average Exercise Price Surrender Of Warrant WeightedAverageExercisePriceSurrenderOfWarrant		shares
CY2022	bant	Weighted Average Remaining Contractual Term Years Surrender Of Warrants WeightedAverageRemainingContractualTermYearsSurrenderOfWarrants
CY2022	bant	Weighted Average Grant Date Fair Value Surrender Of Warrants WeightedAverageGrantDateFairValueSurrenderOfWarrants
CY2022	bant	Weighted Average Grant Date Fair Value Surrender Of Warrant WeightedAverageGrantDateFairValueSurrenderOfWarrant		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet		usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet		usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q3	bant	Less Current Portion LessCurrentPortion		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001704795

Files In Submission

Name	View Source	Status
0001213900-23-002427-index-headers.html	Edgar Link	pending
0001213900-23-002427-index.html	Edgar Link	pending
0001213900-23-002427.txt	Edgar Link	pending
0001213900-23-002427-xbrl.zip	Edgar Link	pending
bant-20220930.xsd	Edgar Link	pending
f10k2022ex31-1_bantecinc.htm	Edgar Link	pending
f10k2022ex31-2_bantecinc.htm	Edgar Link	pending
f10k2022ex32-1_bantecinc.htm	Edgar Link	pending
f10k2022_bantecinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
bant-20220930_def.xml	Edgar Link	unprocessable
bant-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bant-20220930_lab.xml	Edgar Link	unprocessable
f10k2022_bantecinc_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bant-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BANT
Bantec, Inc. Stock $bant

2022 Q4 Form 10-K Financial Statement

#000121390023002427 Filed on January 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT Bantec, Inc. Stock $bant

2022 Q4 Form 10-K Financial Statement

#000121390023002427 Filed on January 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT
Bantec, Inc. Stock $bant